News

News of the day for Dec. 19, 2024

The benchmark US stock measures were pointing higher before the opening bell Thursday as traders dig

Micron shares have lost nearly a third of their value since printing a record high close in June.

Bank of America's share price sits at $43.50 at the time of writing. Brian Moynihan wants to still be in the corner office when it hits $100.

(Bloomberg) -- KKR & Co. is warning that a volatile currency market could be an “Achilles heel” for investors in 2025, as growing deficits and the threat of trade wars may disrupt a bull market that it says still has room to run.Most Read from BloombergNYPD Car Chases Are Becoming More Frequent — and More DangerousDakar’s Air Quality Plummets as Saharan Dust Descends on SenegalThe alternative asset manager said it’s monitoring the dollar and emerging-market currencies heading into the new year,

On Wednesday, the FDA approved Mesoblast Limited’s (NASDAQ:MESO) Ryoncil (remestemcel-L) as the first mesenchymal stromal cell (MSC) therapy in the U.S. Ryoncil is the only MSC therapy approved in the U.S. for any indication and the only therapy for steroid-refractory acute graft versus host disease (SR-aGvHD) in children 2 months and older, including adolescents. Ryoncil contains MSCs, a type of cell that can have various roles in the body and can differentiate into multiple other types of cell

Canoo Inc. (NASDAQ:GOEV) shares are trading lower in the premarket session on Thursday. The company is grappling with major financial challenges, leading to the furlough of 82 employees and the temporary shutdown of its factories in Oklahoma. The move comes as the electric vehicle manufacturer works to secure the necessary capital to continue its operations. Canoo is currently in advanced discussions with multiple capital sources but acknowledges the tough decision to furlough staff, particularl